Tennis star Maria Sharapova's appeal of her two-year tennis ban over doping has been reduced from two years to 15 months, the Court of Arbitration for Sport announced Tuesday.
She will be eligible to compete again April 26, 2017, meaning she will miss the Australian Open but will be able to compete in the French Open.
Sharapova, a five-time Grand Slam champion, was suspended by the International Tennis Federation after testing positive for Meldonium, also known as Mildronate, at the Australian Open in January. The drug is not approved for sale in the United States, where Sharapova trains and lives.